ONCOFID-P-B
Laufzeit: 01.01.2014 - 31.12.2017
Kurzfassung
ONCOFID-P-B (Paclitaxel-Hyaluronic-Acid) in the intravesical therapy of patients with non-muscle invasive cancer of the bladder. A phase II marker lesion study
Laufzeit: 01.01.2014 - 31.12.2017
ONCOFID-P-B (Paclitaxel-Hyaluronic-Acid) in the intravesical therapy of patients with non-muscle invasive cancer of the bladder. A phase II marker lesion study
